[
  {
    "ts": null,
    "headline": "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results",
    "summary": "AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV stock with a Strong Buy rating.",
    "url": "https://finnhub.io/api/news?id=84162b30566b031fd2f5778e89372d55a47095c8c4be23c7927690a903b8a620",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745797235,
      "headline": "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results",
      "id": 134110498,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1193052383/image_1193052383.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV stock with a Strong Buy rating.",
      "url": "https://finnhub.io/api/news?id=84162b30566b031fd2f5778e89372d55a47095c8c4be23c7927690a903b8a620"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says You Should Buy Johnson & Johnson (JNJ), Thinks Talc Problems ‘Behind It’",
    "summary": "We recently published a list of 10 Stocks Analysts are Talking About Amid Trump’s Tariff War. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks analysts are talking about amid Trump’s tariff war. Markets saw some glimmer of hope as President Donald Trump indicated […]",
    "url": "https://finnhub.io/api/news?id=3b773823daed41d082305aa567d2d436258e0eb1bfd83a0657115b0c7947809f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745784070,
      "headline": "Jim Cramer Says You Should Buy Johnson & Johnson (JNJ), Thinks Talc Problems ‘Behind It’",
      "id": 134115090,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Stocks Analysts are Talking About Amid Trump’s Tariff War. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks analysts are talking about amid Trump’s tariff war. Markets saw some glimmer of hope as President Donald Trump indicated […]",
      "url": "https://finnhub.io/api/news?id=3b773823daed41d082305aa567d2d436258e0eb1bfd83a0657115b0c7947809f"
    }
  }
]